Literature DB >> 879928

Prognosis in steroid-treated idiopathic nephrotic syndrome in adults. Analysis of major predictive factors after ten-year follow-up.

B A Idelson, N Smithline, G W Smith, J T Harrington.   

Abstract

This long-term study analyzes the prognostic value of the quantitative urinary protein excretion during and following steroid administration, the renal functional status three years after the onset of disease, and the degree of histologic damage in adult patients with steroid-treated idiopathic nephrotic syndrome (INS). No patient who had a complete (proteinuria less than 0.1 gm/day) or partial (proteinuria less than 2.0 gm/day) remission during steroid administration progressed to renal failure. Furthermore, no patient in whom urinary protein excretion subsequently fell to below 2.0 gm/day ever progressed to renal failure. Only 3 of 49 patients in whom renal function was normal three years after the onset of INS developed renal failure. Finally, renal failure occurred in only 2 of 28 patients with mild abnormalities by light microscopy, compared with 12 of 21 patients with more advanced glomerular abnormalities. Thus, a partial, as well as a complete remission during steroid administration, subsequent reduction in proteinuria to below 2 gm/day, persistence of normal renal function beyond three years, or the presence of mild histologic abnormalities auger a favorable long-term prognosis in patients with INS.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 879928

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  4 in total

1.  Long-term effects of steroid and cytostatic treatment on the clinical course of idiopathic membranous glomerulonephritis (retrospective study).

Authors:  G Mohácsi; A Magori; S Sonkodi
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

Review 2.  Therapy of idiopathic membranous nephropathy.

Authors:  C Ponticelli; P Zucchelli; P Passerini
Journal:  Springer Semin Immunopathol       Date:  1987

3.  Renal pathology of Waldenström's macroglobulinaemia with monoclonal antiglomerular antibodies and nephrotic syndrome.

Authors:  F D Lindström; J Hed; S Eneström
Journal:  Clin Exp Immunol       Date:  1980-08       Impact factor: 4.330

4.  Nephrin Loss Can Be Used to Predict Remission and Long-term Renal Outcome in Patients With Minimal Change Disease.

Authors:  Nina A van de Lest; Malu Zandbergen; Daphne H T IJpelaar; Ron Wolterbeek; Jan A Bruijn; Ingeborg M Bajema; Marion Scharpfenecker
Journal:  Kidney Int Rep       Date:  2017-09-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.